South Korea Regulator Orders Up To 1,000 Drugs Pulled For Asbestos
This article was originally published in PharmAsia News
South Korea's FDA has ordered drug makers, pharmacies and others to trash an estimated 1,000 drugs and medical products containing talc or talcum powders feared to contain asbestos. The names of the products suspected of being contaminated were not yet disclosed. A scare of contamination began with 11 brands of baby powder, but later an estimated 1,000 drugs were known to contain the widely used talc, a key ingredient in making pills, particularly capsules. The Central Pharmaceutical Affairs Review Committee is set to advise the KFDA on which drugs to pull from the market. (Click here for more
You may also be interested in...
Firm supplying all-in-one multivitamin blends rather than packs of multiple pills has four-member advisory board including digital marketing and consumer product marketing specialists and a health care strategist.
UK-headquartered company gets further backing from Novo Ventures and other investors convinced of the potential of NLRP3 inhibitors.
Mylan and Pfizer’s Upjohn have revealed a key date for their merger to create Viatris, after the deal set for midway through the year was pushed back recently due to the coronavirus pandemic.